Delivery Order SPE2DB24D9131-SPE2DB24FXRM4
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the prescription drug Trikafta, which is used to treat cystic fibrosis. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the drug Trikafta, with a completion date of February 13, 2024. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a separate indefinite delivery contract with DLA valued at up to $4,999,999 through 2025 to provide a wide range of pharmaceutical...
This delivery order, valued at $37,053.68, was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the delivery of Trikafta, a specialty pharmaceutical product, and is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA. The IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for...
The Defense Logistics Agency (DLA) awarded a $51,136.76 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Trikafta 100-50-75 mg/75 mg packets, a specialized pharmaceutical product, with a performance period through June 26, 2023. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $36,637.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the delivery of Trikafta tablets, which are used to treat cystic fibrosis. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (#4600082013) with DMS Pharmaceutical Group valued up to $4,999,999 for the supply of a broad range of pharmaceutical items to military health facilities globally. The delivery order is for the drug Trikafta, used to treat...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the branded pharmaceutical drug Trikafta, with a completion date of March 26, 2024. The contract is not designated as a set-aside. DMS Pharmaceutical Group Inc. holds a separate indefinite delivery contract, SPE2DB, with the DLA valued at up to...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a fixed-price pricing type and a completion date of May 16, 2024, is for the delivery of various pharmaceutical products, including Trikafta, a treatment for cystic fibrosis. This contract is part of a larger indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $111,160.98, is for the delivery of Trikafta, a specialty pharmaceutical product, with a period of performance through September 30, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which allows...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, with a period of performance through April 1, 2024, is for the delivery of the pharmaceutical product Trikafta 100-50-75 mg/150 mg. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB22D9102 with DLA, valued at up to...